Should Sponsors Cover 100% of Clinical Trial Costs? – An IRB Perspective
In the United States, most clinical trials are conducted with funding provided by a government agency, industry or other sponsor. Typically, these sponsors cover some…
-
-
Clinical Trial Participant Rights and the Importance of Ethical IRB Review
As the number and complexity of clinical trials continue to grow, so does the imperative to ensure that participants are fully informed about the risks…
-
Gene Therapy in Action: CTLA4 Haploinsufficiency
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Gene Therapy in Action: Fabry Disease
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Gene Therapy In Action: Amyotrophic Lateral Sclerosis (ALS)
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Gene Therapy in Action: Hunter Syndrome (Mucopolysaccharidosis Type II [MPSII])
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Gene Therapy in Action: Thalassemia
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
-
Swift, Responsive Site Support Drives Study Success
A client needed to open 50 U.S. sites for a viral vector cancer vaccine study. Finding sites with the right expertise and facilities was going…
-
Sabai Global Unifies Services, Streamlining Access to Its Comprehensive IRB and IBC Solutions
Sabai is proud to announce the consolidation of its subsidiary service lines—Castle IRB, CBS IBC and Shield Consulting—under one unified brand: Sabai Global. Now, all…
-
Tailor-Built and Thoroughly Trained: Emergency Preparedness using the BioWOPER Methodology from Sabai
Introduction As routine handlers of highly dangerous biological materials and processes, laboratories throughout the biopharmaceutical manufacturing industry are required to possess strict emergency response protocols…
![Gene Therapy in Action: Hunter Syndrome (Mucopolysaccharidosis Type II [MPSII])](https://sabaiglobal.com/wp-content/uploads/2024/09/sab-wp2-768x508.png)
